Maria Bennett

Maria (Walker) Bennett has led SPR Therapeutics since its inception. Prior to the formation of SPR, Ms. Bennett served as the VP of Clinical Affairs at NDI Medical, LLC a medical device development company where she played a vital role in the development of a neurostimulation system addressing urinary incontinence, which was acquired by Medtronic in 2008 company for $42 million. Prior to joining NDI, Ms. Bennett was a Clinical Project Manager at Boston Scientific, leading a team that conducted a large, multi-center clinical trial demonstrating safety and efficacy of an innovative angioplasty balloon, and achieving a 510(k) clearance for this product. Prior to this, she was the Manager of Clinical Studies and Director of Research and Development at NeuroControl Corp., where she co-developed a neurostimulation treatment for post-stroke shoulder pain. In 2009, she was selected by Springboard Enterprises as one of thirty female entrepreneurs from over 100 applicants to present at its LifeScience Venture Forums. She is the inventor of the SPRINT™ System, having patents issued and pending. Ms. Bennett holds a master’s degree in biomedical engineering from Case Western Reserve University and a bachelor’s degree from Miami University (OH) in engineering management.